Editas Medicine

About:

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Website: http://www.editasmedicine.com

Twitter/X: editasmed

Top Investors: Khosla Ventures, Fidelity, Deerfield, Google Ventures, Polaris Partners

Description:

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. The company has generated substantial patent filings and has access to intellectual property covering foundational genome editing technologies, as well as essential advancements and enablements that will uniquely allow the company to translate early findings into viable human therapeutic products. Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. It was founded in 2013 and is headquartered in Cambridge, Massachusetts, the United States with a growing site in Boulder, Colorado.